SAO PAULO (Reuters) – The National Health Surveillance Agency (Anvisa) on Saturday determined the precautionary ban on batches of Chinese vaccine against Covid-19 CoronaVac, prohibiting the distribution and use of batches in a plant not approved in the emergency use authorization , said the regulator in a statement.
According to the statement, Anvisa was informed the day before by the Butantan Institute that Sinovac, the manufacturer of CoronaVac, sent to Brazil 25 batches in the vial-ampoule presentation (single dose and two doses), totaling 12,113,934 doses.
Read Also
- France, girl threatened for spreading videos against Islam: 11 convicted Jul 7, 2021
- A feminist artificial intelligence is possible (and necessary) Jul 6, 2021
- Pokémon Unite is now available for free on iOS / Android and is finally updated with Spanish translation Sep 22, 2021
- After the falls in the Tour: painkillers, sleep and dry needling against the infernal pain Jul 1, 2021
- What to do at the Murcia Fair this Sunday, September 5 Sep 5, 2021
- Twitter will ban its users from posting links to competing social networks Dec 18, 2022
- Train drags stock truck in Tecámac Aug 11, 2021